Results 361 to 370 of about 413,499 (385)
Some of the next articles are maybe not open access.
2019
Hypertrophic cardiomyopathy (HCM) is characterized by the presence of increased left ventricular (LV) wall thickness that is not explained by loading conditions. The LV diastolic function is impaired in the majority of patients, and resting or provocable LV outflow tract obstruction is often present. The management of HCM is directed towards minimizing
openaire +1 more source
Hypertrophic cardiomyopathy (HCM) is characterized by the presence of increased left ventricular (LV) wall thickness that is not explained by loading conditions. The LV diastolic function is impaired in the majority of patients, and resting or provocable LV outflow tract obstruction is often present. The management of HCM is directed towards minimizing
openaire +1 more source
2013
Epidemiology, aetiology, pathophysiology, diagnosis, and therapy of patients with dilated cardiomyopathy are discussed. Recommendations on the use of CRT and ICD therapy by the ACC/AHA and ESC are presented.
Demosthenes G. Katritsis+2 more
openaire +1 more source
Epidemiology, aetiology, pathophysiology, diagnosis, and therapy of patients with dilated cardiomyopathy are discussed. Recommendations on the use of CRT and ICD therapy by the ACC/AHA and ESC are presented.
Demosthenes G. Katritsis+2 more
openaire +1 more source
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Nature Reviews Cardiology, 2021Alida L P Caforio+2 more
exaly
Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies
Nature Reviews Cardiology, 2021R. Walsh+3 more
semanticscholar +1 more source
Molecular mechanism of doxorubicin‐induced cardiomyopathy – An update
European Journal of Pharmacology, 2018Kaviyarasi Renu+3 more
semanticscholar +1 more source
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Ca-A Cancer Journal for Clinicians, 2016Giuseppe Curigliano+2 more
exaly